Alternatives to ONCOMATRYX
The top Biotechnology companies similar to ONCOMATRYX, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
Moderna77BiotechnologyCambridge, United States$4.5B
BeiGene67BiotechCambridge, United States$358.0M- JAJazz Pharmaceuticals50BiotechnologyDublin, Ireland$265.0M
Degron Therapeutics62BiotechnologySan Diego, USA$40.0M
CellCentric60BiotechnologyCambridge, United Kingdom$375.0M
Janux Therapeutics57BiotechnologySan Diego, USA$181.0M
Ella Therapeutics55Life Sciences$15.0M
ImmunityBio50BiotechnologyCulver City, USA$75.0M
Amgen85BiotechThousand Oaks, United States$40.0M
LTZ Therapeutics62BiotechnologyRedwood City, USA$76.0M
Adcendo61BiotechnologyCopenhagen, Denmark$272.0M
Nucleai61HealthcareTel Aviv, Israel$83.5M
Celerion59BiotechnologyLincoln, USA$45.0M
Oncohost57HealthcareTel Aviv, Israel$43.0M- LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
Anagram Therapeutics55BiotechnologyNatick, USA$285.0M
Tozaro54BiotechnologyLondon, United Kingdom$6.9M
Ray Therapeutics54BiotechnologyBerkeley, USA$243.0M
Tortugas Neuroscience53BiotechnologyFramingham, USA$164.0M
Pyxis Diagnostics51HealthcareSan Diego, United States$10.0M
MindWave Innovations51Biotechnology$100.0M
EnteroBiotix50BiotechnologyGlasgow, United Kingdom$40.5M
Orthogon Therapeutics49BiotechnologyCanton, USA$34.6M- AEAelis Farma43BiotechnologyBordeaux, France$54.3M
- SOSOLVE FSHD40BiotechnologyVancouver, Canada$9.2M
- AVAvant GenomicsBiotechnologyCharlottesville, USA$3.0M
Ipsen93BiotechParis, France
Immunai79HealthcareNew York, United States$315.0M
CytoReason79HealthcareTel Aviv, Israel$128.3M
Owkin69Artificial IntelligenceNew York, USA$80.0M
4D Path63BiotechnologyNewton, USA$17.4M
Enterome62BiotechnologyParis, France$123.9M
Cue Biopharma, .62BiotechBoston, United States$10.0M
Imagene62HealthcareTel Aviv, Israel$44.5M
Lunit61HealthTechSeoul, South Korea$1.1B
Cartography Biosciences61BiotechnologySouth San Francisco, USA$150.0M
Verdiva Bio60BiotechnologySan Diego, United States$170.0M
Rocket Pharmaceuticals58BiotechnologyCranbury, USA$382.9M
Kanvas Biosciences57BiotechnologyPrinceton, USA$58.0M
Geneyx Genomex56HealthcareTel Aviv, Israel$10.0M
Pangea Biomed56HealthcareTel Aviv, Israel$24.0M
ScreenPoint Medical55HealthTechNijmegen, Netherlands$30.0M
ImmunoBrain Checkpoint55HealthcareTel Aviv, Israel$10.0M- IMImmuniQ54Life SciencesTel Aviv, Israel
SpliSense54HealthcareRehovot, Israel$28.5M
Latus Bio54BiotechnologyBoston, USA$151.0M
Travere Therapeutics54BiotechnologySan Diego, USA$63.0M
Alector54BiotechSouth San Francisco, United States$162.5M
ProteinQure54BiotechCambridge, United States$15.6M
BiomX53HealthcareNess Ziona, Israel$56.0M
DPEEX52Healthcare$10.0M- ANAN2 Therapeutics46BiotechnologyMenlo Park, United States$132.0M
Naki Health46HealthcareNew York, United States
Ikko Health46HealthcareLondon, United Kingdom$1.0M
AMYGDALA45HealthcareTel Aviv, Israel$1.0M
Adaptimmune Therapeutics44BiotechnologyAbingdon, United Kingdom$107.5M
Gilboa Therapeutics43BiopharmaceuticalsTel Aviv, Israel$10.0M
Viridian Therapeutics, Inc.43BiotechnologyWaltham, United States$350.0M
KAHR Medical42HealthcareJerusalem, Israel$10.0M
Sigint Bio41Biotechפתח תקווה, Israel$100.0M
| Company | Sector | HQ | Funding | Score |
|---|---|---|---|---|
| Biotechnology | Cambridge, United States | $4.5B | 77 | |
| Biotech | Cambridge, United States | $358.0M | 67 | |
| JAJazz Pharmaceuticals | Biotechnology | Dublin, Ireland | $265.0M | 50 |
| Biotechnology | San Diego, USA | $40.0M | 62 | |
| Biotechnology | Cambridge, United Kingdom | $375.0M | 60 | |
| Biotechnology | San Diego, USA | $181.0M | 57 | |
| Life Sciences | — | $15.0M | 55 | |
| Biotechnology | Culver City, USA | $75.0M | 50 | |
| Biotech | Thousand Oaks, United States | $40.0M | 85 | |
| Biotechnology | Redwood City, USA | $76.0M | 62 | |
| Biotechnology | Copenhagen, Denmark | $272.0M | 61 | |
| Healthcare | Tel Aviv, Israel | $83.5M | 61 | |
| Biotechnology | Lincoln, USA | $45.0M | 59 | |
| Healthcare | Tel Aviv, Israel | $43.0M | 57 | |
| LŌLōkahi Therapeutics | Biotechnology | La Jolla, USA | $63.0M | 57 |
| Biotechnology | Natick, USA | $285.0M | 55 | |
| Biotechnology | London, United Kingdom | $6.9M | 54 | |
| Biotechnology | Berkeley, USA | $243.0M | 54 | |
| Biotechnology | Framingham, USA | $164.0M | 53 | |
| Healthcare | San Diego, United States | $10.0M | 51 | |
| Biotechnology | — | $100.0M | 51 | |
| Biotechnology | Glasgow, United Kingdom | $40.5M | 50 | |
| Biotechnology | Canton, USA | $34.6M | 49 | |
| AEAelis Farma | Biotechnology | Bordeaux, France | $54.3M | 43 |
| SOSOLVE FSHD | Biotechnology | Vancouver, Canada | $9.2M | 40 |
| AVAvant Genomics | Biotechnology | Charlottesville, USA | $3.0M | — |
| Biotech | Paris, France | — | 93 | |
| Healthcare | New York, United States | $315.0M | 79 | |
| Healthcare | Tel Aviv, Israel | $128.3M | 79 | |
| Artificial Intelligence | New York, USA | $80.0M | 69 | |
| Biotechnology | Newton, USA | $17.4M | 63 | |
| Biotechnology | Paris, France | $123.9M | 62 | |
| Biotech | Boston, United States | $10.0M | 62 | |
| Healthcare | Tel Aviv, Israel | $44.5M | 62 | |
| HealthTech | Seoul, South Korea | $1.1B | 61 | |
| Biotechnology | South San Francisco, USA | $150.0M | 61 | |
| Biotechnology | San Diego, United States | $170.0M | 60 | |
| Biotechnology | Cranbury, USA | $382.9M | 58 | |
| Biotechnology | Princeton, USA | $58.0M | 57 | |
| Healthcare | Tel Aviv, Israel | $10.0M | 56 | |
| Healthcare | Tel Aviv, Israel | $24.0M | 56 | |
| HealthTech | Nijmegen, Netherlands | $30.0M | 55 | |
| Healthcare | Tel Aviv, Israel | $10.0M | 55 | |
| IMImmuniQ | Life Sciences | Tel Aviv, Israel | — | 54 |
| Healthcare | Rehovot, Israel | $28.5M | 54 | |
| Biotechnology | Boston, USA | $151.0M | 54 | |
| Biotechnology | San Diego, USA | $63.0M | 54 | |
| Biotech | South San Francisco, United States | $162.5M | 54 | |
| Biotech | Cambridge, United States | $15.6M | 54 | |
| Healthcare | Ness Ziona, Israel | $56.0M | 53 | |
| Healthcare | — | $10.0M | 52 | |
| ANAN2 Therapeutics | Biotechnology | Menlo Park, United States | $132.0M | 46 |
| Healthcare | New York, United States | — | 46 | |
| Healthcare | London, United Kingdom | $1.0M | 46 | |
| Healthcare | Tel Aviv, Israel | $1.0M | 45 | |
| Biotechnology | Abingdon, United Kingdom | $107.5M | 44 | |
| Biopharmaceuticals | Tel Aviv, Israel | $10.0M | 43 | |
| Biotechnology | Waltham, United States | $350.0M | 43 | |
| Healthcare | Jerusalem, Israel | $10.0M | 42 | |
| Biotech | פתח תקווה, Israel | $100.0M | 41 |